Autores
HJ Schmoll, Eric Van Cutsem, AESMO Stein, V Valentini, Bengt Glimelius, Karin Haustermans, B Nordlinger, CJ Van de Velde, J Balmana, J Regula, ID Nagtegaal, RG Beets-Tan, D Arnold, F Ciardiello, P Hoff, D Kerr, CH Köhne, R Labianca, T Price, W Scheithauer, A Sobrero, J Tabernero, D Aderka, S Barroso, G Bodoky, JY Douillard, H El Ghazaly, J Gallardo, A Garin, R Glynne-Jones, K Jordan, A Meshcheryakov, D Papamichail, P Pfeiffer, I Souglakos, S Turhal, A Cervantes
Fecha de publicación
2012/10/1
Revista
Annals of oncology
Volumen
23
Número
10
Páginas
2479-2516
Editor
Elsevier
Descripción
Colorectal cancer (CRC) is the most common tumour type in both sexes combined in Western countries. Although screening programmes including the implementation of faecal occult blood test and colonoscopy might be able to reduce mortality by removing precursor lesions and by making diagnosis at an earlier stage, the burden of disease and mortality is still high. Improvement of diagnostic and treatment options increased staging accuracy, functional outcome for early stages as well as survival. Although high quality surgery is still the mainstay of curative treatment, the management of CRC must be a multi-modal approach performed by an experienced multi-disciplinary expert team. Optimal choice of the individual treatment modality according to disease localization and extent, tumour biology and patient factors is able to maintain quality of life, enables long-term survival and even cure in selected patients by a …
Citas totales
20122013201420152016201720182019202020215121184164180162167150180116